Activated Protein C Concentrate: A New Tool for the Treatment of Acute Thromboembolism in Patients with Congenital Protein C Deficiency

Thromb Haemost 1997; 77(06): 1223-1224
DOI: 10.1055/s-0038-1656147

Letters to the Editor

Schattauer GmbH Stuttgart

Authors

Mitsuhiko Sugimoto

The Departments of Paediatrics, Nara Medical University, Kashihara City, Nara, Japan
Yoshiyuki Maruhashi

The Departments of Paediatrics, Nara Medical University, Kashihara City, Nara, Japan
Atsushi Kobayashi

¹2nd Internal Medicine, Nara Medical University, Kashihara City, Nara, Japan
Nobuhiro Narita

¹2nd Internal Medicine, Nara Medical University, Kashihara City, Nara, Japan
Akira Yoshioka

The Departments of Paediatrics, Nara Medical University, Kashihara City, Nara, Japan

References
1 Esmon CT. The regulation of natural anticoagulant pathways. Science 1987; 235: 1348-1351
2 Bertina RM, Broekmans AW. Protein C concentrate for therapeutic use. Lancet 1982; 02: 1348
3 Nakahira S, Miyata K, Sugawara K, Kamai S, Nakahara Y, Ogata Y, Imamura M, Tanigawa H, Nakagaki T, Miyamoto S, Funatsu A. Characterization of purified protein C derived from human plasma. Iyakuhin Kenkyu (in Japanese) 1994; 25: 1087-1097
4 Miyata T, Sakata T, Zheng Y-Z, Tsukamoto H, Umeyama H, Uchiyama S, Ikusawa M, Yoshioka A, Imanaka Y, Fujimura H, Kambayashi J, Kato H. Genetic characterization of protein C deficiency in Japanese subjects using a rapid and nonradioactive method for single-strand conformational polymorphism analysis and a model building. Thromb Haemost 1996; 76: 302-311
5 Sakata Y, Curriden S, Lawrence D, Griffin JH, Loskutoff DJ. Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity. Proc Natl Acad Sci USA 1985; 82: 1121-1125